Ecnoglutide Oral (Sciwind Biosciences)

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameEcnoglutide Oral (Sciwind Biosciences)
Drug Alias NameXW004XW-004VRB-101
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightBody WeightObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHangzhou Sciwind Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVerdiva Bio Dev LtdVerdiva Bio LtdSciwind Biosciences USA Co Ltd +[5] 
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A